Suchergebnisse - "Weinreich, David M"

PubPharm (11)

1

Garetosmab in fibrodysplasia ossificans progressiva : a randomized, double-blind, placebo-controlled phase 2 trial

enthalten in: Nature medicine | 2023

von Di Rocco, M. | Forleo-Neto, E. | Pignolo, R. | +33

2

Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection : A Phase 2 Dose-Ranging Randomized Clinical Trial

enthalten in: JAMA network open | 2022

von Portal-Celhay, C. | Forleo-Neto, E. | Eagan, W. | +127

3

Safety and efficacy of itepekimab in patients with moderate-to-severe COPD : a genetic association study and randomised, double-blind, phase 2a trial

enthalten in: The Lancet. Respiratory medicine | 2021

von Rabe, K. | Celli, B. | Wechsler, M. | +13

CommentIn: Lancet Respir Med. 2021 Nov;9(11):1213-1214. - PMID 34302759

4

Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma

enthalten in: The New England journal of medicine | 2021

von Wechsler, M. | Ruddy, M. | Pavord, I. | +13

5

The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies

enthalten in: Cell | 2021

von Copin, R. | Baum, A. | Wloga, E. | +34

6

Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy : an open-label, multi-centre, single-arm, phase 2 trial

enthalten in: The Lancet. Oncology | 2021

von Stratigos, A. | Sekulic, A. | Peris, K. | +35

CommentIn: Nat Rev Clin Oncol. 2021 Jul;18(7):400. - PMID 34035503

7

Efficacy and safety of fasinumab in patients with chronic low back pain : a phase II/III randomised clinical trial

enthalten in: Annals of the rheumatic diseases | 2021

von Dakin, P. | Kivitz, A. | Gimbel, J. | +8

8

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

enthalten in: The New England journal of medicine | 2021

von Weinreich, D. | Sivapalasingam, S. | Norton, T. | +131

CommentIn: N Engl J Med. 2021 Jan 21;384(3):289-291. - PMID 33471984

9

Cemiplimab in locally advanced cutaneous squamous cell carcinoma : results from an open-label, phase 2, single-arm trial

enthalten in: The Lancet. Oncology | 2020

von Migden, M. | Khushalani, N. | Chang, A. | +19

10

Exposure-response relationship of AMG 386 in combination with weekly paclitaxel in recurrent ovarian cancer and its implication for dose selection

enthalten in: Cancer chemotherapy and pharmacology | 2012

von Lu, J. | Rasmussen, E. | Karlan, B. | +7